The letter was written by Prakash Kumar Singh, Director, Serum Institute of India (SII) on March 27, they said.
He said everyone was looking at India, not just in terms of healthcare but because the country managed to take care of a huge and diverse population and also helped 70 to 80 nations during the COVID-19 pandemic.
The Hyderabad-based Covaxin maker’s nasal vaccine will be introduced on Co-WIN by next week, sources said, adding that the pricing is yet to be decided
According to a top official, this group has the highest population and the least number of people have opted for booster doses in this category.
The Therapeutic Goods Administration (TGA) said it had approved Pfizer’s vaccine for use as a booster in youths aged 16-17, joining the United States, Israel and Britain.
Researchers from Francis Crick Institute and the National Institute for Health Research (NIHR), UK, found that antibodies generated in people who had received only two doses of either the AstraZeneca or the Pfizer vaccine were less able to neutralise Omicron as compared to Alpha and Delta variants.
Regulators had previously authorized boosters for all recipients of Johnson & Johnson's one-dose vaccine, two months after their primary dose.
Australia’s vaccination rate has picked up pace since July, after widely missing its initial targets, when its southeast was hit by a third wave of infections triggered by the highly infectious Delta variant forcing months-long lockdowns.
U.S. health officials may soon recommend COVID-19 booster shots for fully vaccinated Americans. A look at what we know about boosters and how they could help fight the coronavirus.